Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research.
Biol. Blood Marrow Transplant., Nov (2012)
Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation.
J. Clin. Oncol., Aug;29(22):3023-9 (2011)
Unexpected gastrointestinal toxicity from Docetaxel/Carboplatin/Erlotinib followed by maintenance Erlotinib treatment for newly diagnosed stage III/IV ovarian cancer, primary peritoneal, or fallopian tube cancer.
Gynecol. Oncol., May;121(2):426 (2011)
Thymoglobulin and cyclophosphamide as treatment for diffuse cutaneous systemic sclerosis.
J. Rheumatol., Aug;36(8):1839 (2009)
Busulfan in hematopoietic stem cell transplant setting.
Expert Opin Drug Metab Toxicol., Aug;5(8):957-69 (2009)
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.
Biol. Blood Marrow Transplant., Aug;14(8):904-12 (2008)
Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: a phase II trial of the Puget Sound Oncology Consortium.
Gynecol. Oncol., Aug;110(2):146-51 (2008)
The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma.
Bone Marrow Transplant., Dec;40(11):1039-44 (2007)
Immunotherapy with rituximab/interleukin-2 after autologous stem cell transplantation as treatment for CD20+ non-Hodgkin's lymphoma.
Clin Lymphoma Myeloma., Sep;7(2):135-9 (2006)
Revisiting the role of dose intensity in hematological malignancies.
Exp. Hematol., Jul;34(7):811-25 (2006)
Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies.
Int. J. Radiat. Oncol. Biol. Phys., Jan;64(1):227-34 (2006)
Vaccination with Theratope (STn-KLH) as treatment for breast cancer.
Expert Rev Vaccines., Dec;3(6):655-63 (2004)
Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells.
Leuk. Res., Nov;28(11):1177-80 (2004)
Vaccination as a treatment for breast or ovarian cancer.
Expert Rev Vaccines., Jun;3(3):269-77 (2004)
Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation.
Blood., Sep;104(6):1894-7 (2004)
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
Biol. Blood Marrow Transplant., Sep;9(9):583-91 (2003)
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.
Bone Marrow Transplant., Oct;22(7):651-9 (1998)